{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:08:40Z","timestamp":1785305320748,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Australian National Health and Medical Research Council Early Career Fellowship","award":["GNT1141398"],"award-info":[{"award-number":["GNT1141398"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Multidrug resistant organisms (MDROs) occur more commonly in burns patients than in other hospital patients and are an increasingly frequent cause of burn-related mortality. We examined the incidence, trends and risk factors for MDRO acquisition in a specialist burns service housed in an open general surgical ward, and general intensive care unit.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a retrospective study of adult patients admitted with an acute burn injury to our specialist statewide tertiary burns service between July 2014 and October 2020. We linked patient demographics, injury, treatment, and outcome details from our prospective burns service registry to microbiology and antimicrobial prescribing data. The outcome of interest was first MDRO detection, stratified into the following groups of interest: methicillin-resistant<jats:italic>Staphylococcus aureus<\/jats:italic>(MRSA), vancomycin-resistant Enterococcus (VRE), two groups of<jats:italic>Pseudomonas<\/jats:italic>(carbapenem resistant, and piperacillin-tazobactam or cefepime resistant), carbapenem-resistant<jats:italic>Acinetobacter<\/jats:italic>species,<jats:italic>Stenotrophomonas maltophilia<\/jats:italic>, carbapenem-resistant Enterobacteriaceae (CRE), and extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-PE). We used a Cox proportional hazards model to evaluate the association between antibiotic exposure and MDRO acquisition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 2,036 acute admissions, of which 230 (11.3%) had at least one MDRO isolated from clinical specimens, most frequently wound swabs. While acquisition rates of individual MDRO groups varied over the study period, acquisition rate of any MDRO was reasonably stable over time. Carbapenem-resistant<jats:italic>Pseudomonas<\/jats:italic>was acquired at the highest rate over the study period (3.5\/1000 patient days). The 12.8% (29\/226) of MDROs isolated within 48\u00a0h were predominantly MRSA and<jats:italic>Stenotrophomonas.<\/jats:italic>Median (IQR) time from admission to MDRO detection was 10.9 (5.6\u201320.5) days, ranging from 9.8 (2.7\u201324.2) for MRSA to 23.6 (15.7\u201336.0) for carbapenem-resistant<jats:italic>P. aeruginosa<\/jats:italic>. Patients with MDROs were older, had more extensive burns, longer length of stay, and were more likely to have operative burn management. We were unable to detect a relationship between antibiotic exposure and emergence of MDROs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>MDROs are a common and consistent presence in our burns unit. The pattern of acquisition suggests various causes, including introduction from the community and nosocomial spread. More regular surveillance of incidence and targeted interventions may decrease their prevalence, and limit the development of invasive infection.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13756-022-01123-w","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T16:04:39Z","timestamp":1655136279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Patterns of multidrug resistant organism acquisition in an adult specialist burns service: a retrospective review"],"prefix":"10.1186","volume":"11","author":[{"given":"Heather","family":"Cleland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lincoln M.","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Padiglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Stewardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"1123_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/sur.2020.129","volume":"22","author":"PM Robben","year":"2021","unstructured":"Robben PM, Ayalew MD, Chung KK, Ressner RA. Multi-drug-resistant organisms in burn infections. Surg Infect (Larchmt). 2021;22:103\u201312. https:\/\/doi.org\/10.1089\/sur.2020.129.","journal-title":"Surg Infect (Larchmt)"},{"key":"1123_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpubh.2014.00145","volume":"2","author":"CA Michael","year":"2014","unstructured":"Michael CA, Dominey-Howes D, Labbate M. The antimicrobial resistance crisis: causes, consequences, and management. Front Public Heal. 2014;2:1\u20138. https:\/\/doi.org\/10.3389\/fpubh.2014.00145.","journal-title":"Front Public Heal"},{"key":"1123_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/BCR.0000000000000479","volume":"38","author":"I Van Langeveld","year":"2017","unstructured":"Van Langeveld I, Gagnon RC, Conrad PF, Gamelli RL, Martin B, Choudhry MA, et al. Multiple-drug resistance in burn patients: a retrospective study on the impact of antibiotic resistance on survival and length of stay. J Burn Care Res. 2017;38:99\u2013105. https:\/\/doi.org\/10.1097\/BCR.0000000000000479.","journal-title":"J Burn Care Res"},{"key":"1123_CR4","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1093\/cid\/cix682","volume":"65","author":"AM Lachiewicz","year":"2017","unstructured":"Lachiewicz AM, Hauck CG, Weber DJ, Cairns BA, Van Duin D. Bacterial infections after burn injuries: impact of multidrug resistance. Clin Infect Dis. 2017;65:2130\u20136. https:\/\/doi.org\/10.1093\/cid\/cix682.","journal-title":"Clin Infect Dis"},{"issue":"46","key":"1123_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.burns.2019.09.008","volume":"2020","author":"JJ Park","year":"2020","unstructured":"Park JJ, Bin SY, Choi YK, Kym D, Lee J. Changes in the prevalence of causative pathogens isolated from severe burn patients from 2012 to 2017. Burns. 2020;2020(46):695\u2013701. https:\/\/doi.org\/10.1016\/j.burns.2019.09.008.","journal-title":"Burns"},{"key":"1123_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc8170","volume":"13","author":"FN Williams","year":"2009","unstructured":"Williams FN, Herndon DN, Hawkins HK, Lee JO, Cox RA, Kulp GA, et al. The leading causes of death after burn injury in a single pediatric burn center. Crit Care. 2009;13:1\u20137. https:\/\/doi.org\/10.1186\/cc8170.","journal-title":"Crit Care"},{"key":"1123_CR7","doi-asserted-by":"publisher","first-page":"S454","DOI":"10.1097\/sap.0000000000002825","volume":"86","author":"C Wang","year":"2021","unstructured":"Wang C, Zhang F, Breland A, Lineaweaver WC. Efficacy of infection control measures in managing outbreaks of multidrug-resistant organisms in burn units. Ann Plast Surg. 2021;86:S454\u20137. https:\/\/doi.org\/10.1097\/sap.0000000000002825.","journal-title":"Ann Plast Surg"},{"key":"1123_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1089\/sur.2018.301","volume":"20","author":"TL Palmieri","year":"2019","unstructured":"Palmieri TL. Infection prevention: unique aspects of burn units. Surg Infect (Larchmt). 2019;20:111\u20134. https:\/\/doi.org\/10.1089\/sur.2018.301.","journal-title":"Surg Infect (Larchmt)"},{"key":"1123_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.burns.2016.11.001","volume":"43","author":"AL Ho","year":"2017","unstructured":"Ho AL, Chambers R, Malic C, Papp A. Universal contact precautions do not change the prevalence of antibiotic resistant organisms in a tertiary burn unit. Burns. 2017;43:265\u201372. https:\/\/doi.org\/10.1016\/j.burns.2016.11.001.","journal-title":"Burns"},{"key":"1123_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/jbcr\/irab011","volume":"42","author":"E Gus","year":"2021","unstructured":"Gus E, Almeland SK, Barnes D, Elmasry M, Singer Y, Sj\u00f6berg F, et al. Burn unit design-the missing link for quality and safety. J Burn Care Res. 2021;42:369\u201375. https:\/\/doi.org\/10.1093\/jbcr\/irab011.","journal-title":"J Burn Care Res"},{"key":"1123_CR11","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","volume":"17","author":"D Baur","year":"2017","unstructured":"Baur D, Gladstone BP, Burkert F, Carrara E, Foschi F, D\u00f6bele S, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17:990\u20131001. https:\/\/doi.org\/10.1016\/S1473-3099(17)30325-0.","journal-title":"Lancet Infect Dis"},{"key":"1123_CR12","unstructured":"Australian Bureau of Statistics. Quarterly Population estimates (ERP), by State\/Territory, Sex and Age, Victoria 2008\u20132017,ABS stat(beta) n.d."},{"key":"1123_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.2010.05635.x","author":"BJ Gabbe","year":"2011","unstructured":"Gabbe BJ, Cleland HJ, Cameron PA. Profile, transport and outcomes of severe burns patients within an inclusive, regionalized trauma system. ANZ J Surg. 2011. https:\/\/doi.org\/10.1111\/j.1445-2197.2010.05635.x.","journal-title":"ANZ J Surg"},{"key":"1123_CR14","unstructured":"R Core Team RF for SC. R: a language and environment for statistical computing. Vienna, Austria: n.d."},{"key":"1123_CR15","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, Chang W, D\u2019Agostino McGowan L, Fran\u00e7ois R, et al. Welcome to the tidyverse. J Open Source Softw. 2019;4:1686.","journal-title":"J Open Source Softw"},{"key":"1123_CR16","doi-asserted-by":"publisher","unstructured":"Kay M. Visualizations of distributions and uncertainty;2021. https:\/\/doi.org\/10.5281\/zenodo.3879620","DOI":"10.5281\/zenodo.3879620"},{"key":"1123_CR17","doi-asserted-by":"crossref","unstructured":"Tiedemann F. gghalves: compose half-half plots using your favourite geoms;2020.","DOI":"10.32614\/CRAN.package.gghalves"},{"key":"1123_CR18","doi-asserted-by":"crossref","unstructured":"Therneau T, Grambsch P. modeling survival data: extending the cox model;2000.","DOI":"10.1007\/978-1-4757-3294-8"},{"key":"1123_CR19","unstructured":"Therneau T. A package for survival analysis in R;2020."},{"key":"1123_CR20","unstructured":"Kassambara A, Kosinski M, Biecek P. survminer: drawing survival curves using \u201cggplot2\u201d;2021."},{"key":"1123_CR21","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.ajic.2016.07.027","volume":"44","author":"D van Duin","year":"2016","unstructured":"van Duin D, Strassle PD, DiBiase LM, Lachiewicz AM, Rutala WA, Eitas T, et al. Timeline of health care\u2013associated infections and pathogens after burn injuries. Am J Infect Control. 2016;44:1511\u20136. https:\/\/doi.org\/10.1016\/j.ajic.2016.07.027.","journal-title":"Am J Infect Control"},{"key":"1123_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.burns.2009.10.013","volume":"36","author":"EF Keen","year":"2010","unstructured":"Keen EF, Robinson BJ, Hospenthal DR, Aldous WK, Wolf SE, Chung KK, et al. Prevalence of multidrug-resistant organisms recovered at a military burn center. Burns. 2010;36:819\u201325. https:\/\/doi.org\/10.1016\/j.burns.2009.10.013.","journal-title":"Burns"},{"key":"1123_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2020.12.007","author":"JR Gallaher","year":"2020","unstructured":"Gallaher JR, Banda W, Lachiewicz AM, Krysiak R, Purcell LN, Charles AG. Predictors of multi-drug resistance in burn wound colonization following burn injury in a resource-limited setting. Burns. 2020. https:\/\/doi.org\/10.1016\/j.burns.2020.12.007.","journal-title":"Burns"},{"key":"1123_CR24","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.burns.2017.01.016","volume":"43","author":"NP Singh","year":"2017","unstructured":"Singh NP, Rani M, Gupta K, Sagar T, Kaur IR. Changing trends in antimicrobial susceptibility pattern of bacterial isolates in a burn unit. Burns. 2017;43:1083\u20137. https:\/\/doi.org\/10.1016\/j.burns.2017.01.016.","journal-title":"Burns"},{"key":"1123_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.burns.2009.10.012","volume":"36","author":"EF Keen","year":"2010","unstructured":"Keen EF, Robinson BJ, Hospenthal DR, Aldous WK, Wolf SE, Chung KK, et al. Incidence and bacteriology of burn infections at a military burn center. Burns. 2010;36:461\u20138. https:\/\/doi.org\/10.1016\/j.burns.2009.10.012.","journal-title":"Burns"},{"key":"1123_CR26","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.burns.2015.05.007","volume":"41","author":"IA Bahemia","year":"2015","unstructured":"Bahemia IA, Muganza A, Moore R, Sahid F, Menezes CN. Microbiology and antibiotic resistance in severe burns patients: a 5 year review in an adult burns unit. Burns. 2015;41:1536\u201342. https:\/\/doi.org\/10.1016\/j.burns.2015.05.007.","journal-title":"Burns"},{"key":"1123_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1086\/508841","volume":"28","author":"S Herbert","year":"2007","unstructured":"Herbert S, Halvorsen DS, Leong T, Franklin C, Harrington G, Spelman D, et al. Large outbreak of infection and colonization with gram - negative pathogens carrying the metallo - \u03b2 - lactamase gene blaIMP - 4 at a 320 - bed tertiary hospital in Australia. Infect Control Hosp Epidemiol. 2007;28:98\u2013101.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1123_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.burns.2005.08.016","volume":"32","author":"WP Tsai","year":"2006","unstructured":"Tsai WP, Chen CL, Ko WC, Pan SC. Stenotrophomonas maltophilia bacteremia in burn patients. Burns. 2006;32:155\u20138. https:\/\/doi.org\/10.1016\/j.burns.2005.08.016.","journal-title":"Burns"},{"key":"1123_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2017.02276","volume":"8","author":"AA Adegoke","year":"2017","unstructured":"Adegoke AA, Stenstr\u00f6m TA, Okoh AI. Stenotrophomonas maltophilia as an emerging ubiquitous pathogen: looking beyond contemporary antibiotic therapy. Front Microbiol. 2017;8:1\u201318. https:\/\/doi.org\/10.3389\/fmicb.2017.02276.","journal-title":"Front Microbiol"},{"key":"1123_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15123-0","author":"MI Gr\u00f6schel","year":"2020","unstructured":"Gr\u00f6schel MI, Meehan CJ, Barilar I, Diricks M, Gonzaga A, Steglich M, et al. The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-15123-0.","journal-title":"Nat Commun"},{"key":"1123_CR31","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/ans.15393","volume":"89","author":"ML Vickers","year":"2019","unstructured":"Vickers ML, Malacova E, Milinovich GJ, Harris P, Eriksson L, Dulhunty JM, et al. Modifiable risk factors for multidrug-resistant Gram-negative infection in critically ill burn patients: a systematic review and meta-analysis. ANZ J Surg. 2019;89:1256\u201360. https:\/\/doi.org\/10.1111\/ans.15393.","journal-title":"ANZ J Surg"},{"key":"1123_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmi.2019.05.013","volume":"26","author":"E Tacconelli","year":"2020","unstructured":"Tacconelli E, G\u00f3rska A, De Angelis G, Lammens C, Restuccia G, Schrenzel J, et al. Estimating the association between antibiotic exposure and colonization with extended-spectrum \u03b2-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study. Clin Microbiol Infect. 2020;26:87\u201394. https:\/\/doi.org\/10.1016\/j.cmi.2019.05.013.","journal-title":"Clin Microbiol Infect"},{"key":"1123_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1086\/514909","volume":"27","author":"REW Hancock","year":"1998","unstructured":"Hancock REW. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis. 1998;27:93\u20139. https:\/\/doi.org\/10.1086\/514909.","journal-title":"Clin Infect Dis"},{"key":"1123_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jhin.2017.06.015","volume":"97","author":"G Ramos","year":"2017","unstructured":"Ramos G, Cornistein W, Cerino GT, Nacif G. Systemic antimicrobial prophylaxis in burn patients: systematic review. J Hosp Infect. 2017;97:105\u201314. https:\/\/doi.org\/10.1016\/j.jhin.2017.06.015.","journal-title":"J Hosp Infect"},{"key":"1123_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.addr.2017.09.019","volume":"123","author":"AA Udy","year":"2018","unstructured":"Udy AA, Roberts JA, Lipman J, Blot S. The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: an appraisal utilizing antibiotics. Adv Drug Deliv Rev. 2018;123:65\u201374. https:\/\/doi.org\/10.1016\/j.addr.2017.09.019.","journal-title":"Adv Drug Deliv Rev"},{"key":"1123_CR36","doi-asserted-by":"publisher","unstructured":"Sehgal P, Elligsen M, Lo J, Lam PW, Leis JA, Fowler R, et al. Long-term sustainability and acceptance of antimicrobial stewardship in intensive care: a retrospective cohort study. Crit Care Med;2020. https:\/\/doi.org\/10.1097\/CCM.0000000000004698.","DOI":"10.1097\/CCM.0000000000004698"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01123-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01123-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01123-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T21:42:07Z","timestamp":1727386927000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01123-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1123"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01123-w","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"assertion":[{"value":"24 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this project was provided by Alfred Health Human Research Committee (#154\/20).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}